- Global Pharma News & Resources

Press Releases - 2020-01-30

Date Title Company
30-Jan-2020 Coronavirus: New Gear Offers Protection For Patients And Healthcare Workers Radiation Shield Technologies
30-Jan-2020 CannTrust Provides Default Status Report CannTrust Holdings Inc.
30-Jan-2020 Announcement under the Irish Takeover Rules: Relevant Securities in Issue - January 30, 2020 Allergan plc
30-Jan-2020 Intec Pharma Announces Proposed Public Offering Intec Pharma Ltd.
30-Jan-2020 Amgen Reports Fourth Quarter And Full Year 2019 Financial Results Amgen
30-Jan-2020 Aprecia Appoints Amol Matharu Chief Scientific Officer Aprecia Pharmaceuticals
30-Jan-2020 Rani Therapeutics Announces Positive Phase I Study Results of Oral Octreotide using RaniPill(TM) Rani Therapeutics
30-Jan-2020 AnPac Bio Announces Pricing of Initial Public Offering AnPac Bio-Medical Science Co., Ltd.
30-Jan-2020 GreenLight Opens New Location at Research Triangle Park in North Carolina GreenLight
30-Jan-2020 Vizgen Launches with $14M Series A Financing Led by ARCH Venture Partners and Northpond Ventures Vizgen
30-Jan-2020 Vetter Aligns its Development Service Laboratory Portfolio Under One Roof B3C newswire
30-Jan-2020 Key Biologics Fills Critical Leadership Positions for High-Growth Business Key Biologics
30-Jan-2020 Abbott's Tendyne(TM) Device Receives World's First CE Mark for Transcatheter Mitral Valve Implantation Abbott
30-Jan-2020 Neogen, Angus Genetics launch improved Angus GS(SM) Neogen Corporation
30-Jan-2020 Agencies Expect Possible Treatments and Hope for a Coronavirus Vaccine as Soon as Three Months USA News Group
30-Jan-2020 VistaGen Therapeutics Receives FDA Clearance of IND for Phase 2 Clinical Study of AV-101 as a Potential Treatment of Dyskinesia in Parkinson's Disease Patients VistaGen Therapeutics
30-Jan-2020 Lily Bioceutical's Successful Product Launch For Beyond Flawless® Second Skin Opens Lucrative New Category For Beauty Retailers Lily Bioceuticals
30-Jan-2020 SutroVax Announces Executive Appointment SutroVax
30-Jan-2020 Arcadia Biosciences Letter to Shareholders Arcadia Biosciences, Inc.
30-Jan-2020 Pulmatrix Receives Fast Track Designation for Pulmazole for the Treatment of Asthma-ABPA Pulmatrix, Inc.